[Treatment of purulent meningitis with ceftriaxone].
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001929:Brain Edema / Q000209:etiology; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000134:cerebrospinal fluid / Q000627:therapeutic use; D002443:Ceftriaxone; D002511:Cephalosporins / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007700:Kinetics; D008581:Meningitis / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D010406:Penicillins / Q000627:therapeutic use; D012769:Shock / Q000628:therapy
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins; D002701:Chloramphenicol; D002443:Ceftriaxone; D002439:Cefotaxime
Die Behandlung der eitrigen Meningitis mit Ceftriaxon.